loader2
Partner With Us NRI

Global Longlife Hospital and Research Ltd share Price Today

Company details

27.99
29.90
27.00
61.70
6M Return -36.13%
1Y Return -23.62%
Mkt Cap.(Cr) 31.28
Volume 31,000
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 31,000

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Global Longlife Hospital and Research Ltd shares SWOT Analysis

Strengths (2)

  • Company with Low Debt
  • Company with Zero Promoter Pledge

Weakness (9)

  • MACD Crossover Below Signal Line
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (2)

  • Positive Breakout Third Resistance ( LTP > R3)
  • Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Threats (1)

  • RSI indicating price weakness

Resistance and support

R1 30.5
R2 31.2
R3 32.4
Pivot

29.24

S1 28.6
S2 27.3
S3 26.7
EMA SMA
31.3
33.3
36.6
41.5
31.2
32.4
37.6
42.1
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
HARSHAD RASIKLAL SHETH Bulk Sell 2024-07-24 30.4 100000 BSE
JITENDRA RASIKLAL SANGHAVI Bulk Purchase 2024-06-11 32 65000 BSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Purchase 2024-06-11 27 58000 BSE
Name Category Shares
DHRUV SURESHKUMAR JANI PROMOTER 22.85%
SUCHETA DHRUVKUMAR JANI PROMOTER 17.14%
SURESHKUMAR BABULAL JANI PROMOTER 14.29%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Global Longlife Hospital and Research Ltd Stocks COMPARISON

Financials( in Cr) Global Longlife Hospital and Research Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Syngene International Ltd
Price 29.79 6,686.90 885.15 532.80 830.95
% Change 0.61 2.63 1.74 2.04 1.86
Mcap Cr 31.28 96,147.59 86,028.79 40,224.16 33,448.81
Revenue TTM Cr 23.50 16,612.50 4,831.37 7,175.67 3,488.60
Net Profit TTM Cr 1.83 887.50 1,103.51 645.22 510.00
PE TTM 0.00 92.82 81.61 62.71 70.13
1 Year Return -23.62 38.71 69.67 69.76 4.66
ROCE 6.33 14.16 13.85 9.65 13.56
ROE 4.50 15.04 16.12 7.81 12.95
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 64.29 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 37,516.17 -14,555.25
LAST 3M 90,902.40 37,557.41
LAST 6M 198,345.87 43,710.77
LAST 12M 329,168.77 54,053.10

Global Longlife Hospital and Research Ltd Information

Stock PE (TTM)
0
Promoter Holding
54.29%
Book Value
24.6952
ROCE
6.33%
ROE
4.5%
Description
  • Global Longlife Hospital and Research Limited was originally incorporated as "Global Longlife Hospital and Research Private Limited" as a Private Limited Company on January 20, 2012 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, Company was converted into a Public Limited Company and consequently, name of the Company was changed to "Global Longlife Hospital and Research Limited" vide fresh Certificate of Incorporation dated August 31, 2021. Mr. Suresh Jani along with the team of doctors and the investors have incorporated the Company to bring healthcare of international standards within the reach of every individual. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in the month of March 2012, within approximately two months from the incorporation of the Company. The Promoter with the help of the Doctor team had completed the Hospital within a period of three years and started hospital in the year 2015-16. Mr. Dhruv Jani had also joined the hospital business with his father in the month of July 2015.The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017. At present the Promoters along with his family members hold 81.43 % stake in the Company. The Company is known as a Multi Speciality Tertiary Care Hospital of Gujarat with 110 beds well equipped for Medical & Surgical Specialities. As a policy, any doctor having experience of more than 3 years can admit his patient in the hospital. The Company provide platform to the doctors for treatment of their patients. Apart from the 11 full time consultants, the Hospital has a team of more than 30 experienced doctors as a consultant to serve patients. Its staff strength comprises 37 nursing staff and more than 50 paramedical, corporate and support staff and pharmacists. The Company has invested in, and established a IT system both for clinical purposes as well as integrating systems and processes through HMS (Hospital Management System) which includes Central Registration Module, Appointment, Barcode Generation, Case Paper Generation, OPD Billing, Procedure billing, IPD Registration, Advance & Refund, Due billing, TPA/Package Billing, User Management, Doctor Sharing, Software Security, Management Reports, Discharge Summary towards streamlining clinical and administrative functions. The Company also adopted technology to ensure quick transmission of disease data, subsequent analysis, and prompt disease management. Hospital business mainly depends on the skills of Medical Practitioners and the quality of services provided by the healthcare staff members. Apart from the Full time doctors, the Hospital has a well experienced team of consultants of various field of medicines to provide the quality healthcare services to the patients. The dedicated team is trained to take care of the patients and handle all kinds of emergencies. Its healthcare staff members comprise of Medical Director, Quality Manager, Clinical Pharmacist, Microbiologist, Medical Officers, Clinical Assistants, Infection Control Nurse, Nursing staff, Attendants, Paramedical staff, Dietician/ Nutritionist, Medical Transcriber, Biomedical Engineers and etc. who all are well trained for their services toward its patients. The Hospital provide comprehensive healthcare services across a range of specialties and super-specialties. These include Cardiology, Allergy and immunology, oncology, Diabetes & Endocrinology, Anesthesiology, Pain Management, Internal Medicine , Nephrology, Neurology, Dermatology, plastic Surgery and others. The hospital has been awarded "The Best Emerging Hospital" by Times of India. It offer various health care services at affordable prices. The Company came up with Initial Public Issue of 35,00,000 Equity Shares of Face value of Rs. 10/- each, aggregating to Rs. 49 crores and the resultant, the Company` Shares got listed on May 04, 2022 on SME Platform of BSE Limited.

Registered Address

Global Hospital Opp. Auda Gar., Near Water Tank Bodakdev, Ahmedabad, Gujarat, 380054

Tel : 91-079-29700082
Email : investor:globalhospital.co.in
Website : http://www.globalhospital.co.in
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1000
BSE Code : 543520
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : M
ISIN : INE0J2K01014

FAQ’s on Global Longlife Hospital and Research Ltd Shares

You can buy Global Longlife Hospital and Research Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Global Longlife Hospital and Research Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Aug 16, 2024 04:01 PM the closing price of Global Longlife Hospital and Research Ltd was Rs.29.79.

The latest PE ratio of Global Longlife Hospital and Research Ltd as of Aug 16, 2024 04:01 PM is 0.00

The latest PB ratio of Global Longlife Hospital and Research Ltd as of Aug 16, 2024 04:01 PM is 0.83

The 52-week high of Global Longlife Hospital and Research Ltd share price is Rs. 61.70 while the 52-week low is Rs. 27.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Aug 16, 2024 04:01 PM, the market cap of Global Longlife Hospital and Research Ltd stood at Rs. 31.28 Cr.

Download App

Download Our App

Play Store App Store
market app